FDA Inspection 1231021 — Missouri Center For Reproductive Medicine LLC
The FDA completed an inspection of Missouri Center For Reproductive Medicine LLC on Feb 8, 2024 in Chesterfield, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 8, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Chesterfield, MO (United States)